Sophia Adamia Selected Research

Sophia Adamia Research Topics

Disease

14	Neoplasms (Cancer) 01/2020 - 04/2003
12	Multiple Myeloma 06/2022 - 08/2004
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2020 - 09/2010
5	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2009 - 03/2005
4	Leukemia 12/2020 - 05/2008
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2013 - 05/2008
2	Breast Neoplasms (Breast Cancer) 01/2014 - 03/2011
2	Carcinogenesis 05/2013 - 02/2005
2	Disease Progression 12/2008 - 06/2005
1	Systemic Mastocytosis 11/2019
1	Genomic Instability 03/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2015
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 05/2010
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2010
1	Lymphoma (Lymphomas) 01/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2009
1	Paraproteinemias (Monoclonal Gammopathy) 08/2007
1	Residual Neoplasm 07/2007

Drug/Important Bio-Agent (IBA)

8	Hyaluronan SynthasesIBA 01/2014 - 04/2003
5	Hyaluronic Acid (Hyaluronan)IBA 01/2014 - 04/2003
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 04/2003
3	Phosphotransferases (Kinase)IBA 11/2019 - 01/2011
3	Pharmaceutical PreparationsIBA 09/2013 - 05/2008
2	Monoclonal AntibodiesIBA 11/2020 - 08/2007
2	MicroRNAs (MicroRNA)IBA 01/2020 - 10/2010
2	RNA Precursors (Precursor, mRNA)IBA 01/2014 - 05/2013
2	Imatinib Mesylate (Gleevec)FDA Link 09/2013 - 05/2008
2	Indicators and Reagents (Reagents)IBA 05/2013 - 06/2005
2	Immunoglobulin M (IgM)IBA 09/2007 - 08/2007
1	venetoclaxIBA 12/2020
1	S63845IBA 12/2020
1	daratumumabIBA 11/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	UbiquitinIBA 01/2020
1	gilteritinibIBA 11/2019
1	avapritinibIBA 11/2019
1	midostaurinIBA 11/2019
1	tyrosine receptor (receptor, tyrosine)IBA 11/2019
1	quizartinibIBA 11/2019
1	crenolanibIBA 11/2019
1	Sorafenib (BAY 43-9006)FDA Link 11/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2019
1	alpha-hydroxyglutarateIBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2016
1	NAD (NADH)IBA 03/2016
1	N- (4- (1- benzoylpiperidin- 4- yl)butyl)- 3- (pyridin- 3- yl)acrylamideIBA 09/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2015
1	Nicotinamide PhosphoribosyltransferaseIBA 09/2015
1	Lenalidomide (CC 5013)FDA Link 04/2011
1	Biomarkers (Surrogate Marker)IBA 03/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2010
1	Platelet-Derived Growth Factor alpha ReceptorIBA 05/2010
1	Adenosine Triphosphate (ATP)IBA 05/2010
1	nasIBA 01/2009
1	NucleosidesIBA 01/2009
1	nilotinib FDA Link 05/2008
1	Tyrosine Kinase InhibitorsIBA 05/2008
1	Immunologic Factors (Immunomodulators)IBA 08/2007
1	LigandsIBA 08/2007
1	CholesterolIBA 08/2007
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 08/2007
1	Biological ProductsIBA 08/2007
1	Thalidomide (Thalomid)FDA Link 08/2007
1	Bortezomib (Velcade)FDA Link 08/2007
1	Rituximab (Mabthera)FDA Link 08/2007
1	Stem Cell FactorIBA 08/2007
1	Protein Kinase C betaIBA 08/2007
1	B-Cell Activating FactorIBA 08/2007
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2007
1	DNA (Deoxyribonucleic Acid)IBA 10/2005
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2005
1	Protein Isoforms (Isoforms)IBA 08/2004

Therapy/Procedure

10	Therapeutics 06/2022 - 07/2007
1	Drug Therapy (Chemotherapy) 01/2019
1	Stem Cell Transplantation 08/2007
1	Ambulatory Care (Outpatient Care) 10/2005
1	Microelectrodes 09/2004